Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Keefe, Bruyette & Woods reiterated its Market Perform rating on American Financial Group, Inc. (NYSE:AFGD) on October 12, 2026.
Read moreNeedham reiterated its Buy rating on Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) on October 12, 2026.
Read moreCitizens reiterated its Market Outperform rating on Slide Insurance Holdings, Inc. Common Stock (NASDAQ:SLDE) on October 12, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on Mineralys Therapeutics, Inc.
Read moreUBS analysts initiated coverage on Mineralys Therapeutics, Inc. (NASDAQ:MLYS) with a rating of Neutral on October 12, 2026.
Read moreCitigroup analysts upgraded Allison Transmission Holdings, Inc. (NYSE:ALSN) from Neutral to Buy on October 12, 2026.
Read moreTruist Securities analysts upgraded First Solar, Inc. (NASDAQ:FSLR) from Hold to Buy on October 12, 2026.
Read moreMaxim Group analysts initiated coverage on Eva Live, Inc. (OTC:GOAI) with a rating of Buy on October 12, 2026.
Read moreCitizens reiterated its Market Outperform rating on aTyr Pharma, Inc. (NASDAQ:LIFE) on October 12, 2026.
Read moreBTIG reiterated its Buy rating on SHOULDER INNOVATIONS, INC. (NYSE:SI) on October 12, 2026.
Read moreHC Wainwright & Co. reiterated its Buy rating on SOPHiA GENETICS S.A.
Read moreKeefe, Bruyette & Woods reiterated its Market Perform rating on American Financial Group, Inc. (NYSE:AFGC) on October 12, 2026.
Read moreNeedham reiterated its Buy rating on Enovis Corporation (NYSE:ENOV) on October 12, 2026.
Read moreUBS analysts initiated coverage on Ocular Therapeutix, Inc. (NASDAQ:OCUL) with a rating of Buy on October 12, 2026.
Read moreBaird analysts upgraded Hub Group, Inc. (NASDAQ:HUBG) from Neutral to Outperform on October 12, 2026.
Read moreRBC Capital reiterated its Sector Perform rating on Commault Systems, Inc. (NASDAQ:CVLT) on October 12, 2026.
Read moreStifel reiterated its Buy rating on Vail Resorts, Inc. (NYSE:MTN) on October 12, 2026.
Read moreUBS analysts initiated coverage on Protagonist Therapeutics, Inc. (NASDAQ:PTGX) with a rating of Buy on October 12, 2026.
Read moreSeaport Global analysts upgraded Hexcel Corporation (NYSE:HXL) from Neutral to Buy on October 12, 2026.
Read moreRBC Capital reiterated its Sector Perform rating on Lear Corporation (NYSE:LEA) on October 12, 2026.
Read more
